O75909 (CCNK_HUMAN) Homo sapiens (Human)

Cyclin-K UniProtKBInterProSTRINGInteractive Modelling

580 aa; Sequence (Fasta) ; (Isoform 2; Isoform 1; Isoform 4); 5 identical sequences: Pongo abelii: A0A6D2XS62; Theropithecus gelada: A0A8D2JWZ1; Papio anubis: A0A096NJP9; Macaca mulatta: F7DAF2; Cercocebus atys: A0A2K5N2N4

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of the Human Cdk12-Cyclink Complex Heteromer
Q9NYV4;
20-267
5I1;
Assess
Structure of DDB1 bound to DS17-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
GOL;RQL;
Assess
Structure of DDB1 bound to DS16-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
10×SO4;RNF;
Assess
Structure of DDB1 bound to DS22-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RQL;
Assess
Structure of DDB1 bound to DS18-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
12×SO4;RVQ;
Assess
Structure of DDB1 bound to SR-4835-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RMF;CIT;
Assess
Structure of DDB1 bound to 919278-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
CIT;RVH;
Assess
Structure of DDB1 bound to DS43-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
CIT;RQ9;
Assess
Structure of DDB1 bound to Z7-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
10×SO4;RP9;
Assess
Structure of DDB1 bound to 21195-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
EDO;RS5; 10×SO4;
Assess
Structure of DDB1 bound to DS61-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RQ5;
Assess
Structure of DDB1 bound to Z11-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
12×SO4;RVU;
Assess
Structure of DDB1 bound to DS59-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RMX;
Assess
Structure of DDB1 bound to DS15-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
11×SO4;T6X;
Assess
Structure of DDB1 bound to DS11-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
EDO;SO4;RSU;
Assess
Structure of DDB1 bound to DS30-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
11×SO4;RWN;
Assess
Structure of DDB1 bound to DS08-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RWE;
Assess
Structure of DDB1 bound to dCeMM4-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
CIT;RNU;
Assess
Structure of DDB1 bound to DS19-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
EDO;SO4;RSI;
Assess
Structure of DDB1 bound to DS55-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RQE;
Assess
Structure of DDB1 bound to CR8-engaged CDK12-cyclinK Heteromer
Q16531; Q9NYV4;
20-267
RC8;
Assess
Structure of DDB1 bound to DRF-053-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
EDO;SO4;RV6;
Assess
Structure of DDB1 bound to roscovitine-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RRC;
Assess
Structure of DDB1 bound to HQ461-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
CIT;RPW;
Assess
Structure of DDB1 bound to DS24-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RLC;
Assess
Structure of DDB1 bound to DS06-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RUW;
Assess
Structure of DDB1 bound to DS50-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RQU;
Assess
Structure of DDB1 bound to WX3-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RR9;
Assess
Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-267
SO4;RKO;
Assess
Structure of DDB1 bound to Z12-engaged CDK12-cyclin K Heteromer
Q16531; Q9NYV4;
20-266
12×SO4;RW6;
Assess
Crystal structure of human Cdk12/Cyclin K in complex with ADP-aluminum fluoride Heteromer
Q9NYV4;
20-265
ADP;AF3;MG;EDO;
Assess
Crystal structure of human Cdk12/Cyclin K in complex with the inhibitor BSJ-01-175 Heteromer
Q9NYV4;
20-265
UUB;
Assess
Crystal structure of human Cdk13/Cyclin K in complex with the inhibitor THZ531 Heteromer
Q14004;
21-264
5I1;
Assess
Crystal structure of human Cdk13/Cyclin K in complex with ADP-aluminum fluoride Heteromer
Q14004;
21-262
ADP;AF3;MG;
Assess
Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP Heteromer
Q9NYV4;
22-262
Assess
Crystal structure of human CDK12/CyclinK in complex with an inhibitor Heteromer
Q9NYV4;
20-259
MG;CJM;EDO;
Assess
Crystal structure of human Cdk12/Cyclin K in complex with inhibitor SR-4835 Heteromer
Q9NYV4;
22-260
RMF;
Assess
Crystal structure of the human CDK12-cyclinK complex Heteromer
Q9NYV4;
22-260
Assess
Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)p… Heteromer
Q9NYV4;
22-259
MG;8M1;
Assess
Crystal structure of Cyclin Kmonomer14-267
ACT;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6ckx.2.Bmonomer0.5622-259
100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 16td3.1.Cmonomer0.9020-264
100.00
Assess
Isoform 26td3.1.Cmonomer0.9020-264
100.00
Assess
Isoform 46ckx.2.Bmonomer0.5522-259
100.00
Assess